214 related articles for article (PubMed ID: 30076985)
1. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
Chan MKH; Chiang CL
Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
[TBL] [Abstract][Full Text] [Related]
3. Modeling of the resensitization effect on carbon-ion radiotherapy for stage I non-small cell lung cancer.
Inaniwa T; Kanematsu N; Nakajima M
Phys Med Biol; 2024 May; 69(10):. PubMed ID: 38604184
[No Abstract] [Full Text] [Related]
4. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
6. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
Jeong J; Taasti VT; Jackson A; Deasy JO
Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
[TBL] [Abstract][Full Text] [Related]
7. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
[TBL] [Abstract][Full Text] [Related]
8. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
[TBL] [Abstract][Full Text] [Related]
9. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
[TBL] [Abstract][Full Text] [Related]
10. Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
Stephans KL; Woody NM; Reddy CA; Varley M; Magnelli A; Zhuang T; Qi P; Videtic GMM
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):462-469. PubMed ID: 29353658
[TBL] [Abstract][Full Text] [Related]
11. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer.
Singer JM; Price P; Dale RG
Br J Cancer; 1998 Dec; 78(12):1629-33. PubMed ID: 9862575
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
Lu JY; Lin Z; Lin PX; Huang BT
J Cancer; 2019; 10(19):4655-4661. PubMed ID: 31528230
[No Abstract] [Full Text] [Related]
14. Fractionated carbon ion irradiations of the rat spinal cord: comparison of the relative biological effectiveness with predictions of the local effect model.
Saager M; Glowa C; Peschke P; Brons S; Grün R; Scholz M; Debus J; Karger CP
Radiat Oncol; 2020 Jan; 15(1):6. PubMed ID: 31900185
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.
Mehta N; King CR; Agazaryan N; Steinberg M; Hua A; Lee P
Pract Radiat Oncol; 2012; 2(4):288-295. PubMed ID: 24674167
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.
Klement RJ; Sonke JJ; Allgäuer M; Andratschke N; Appold S; Belderbos J; Belka C; Dieckmann K; Eich HT; Flentje M; Grills I; Eble M; Hope A; Grosu AL; Semrau S; Sweeney RA; Hörner-Rieber J; Werner-Wasik M; Engenhart-Cabillic R; Ye H; Guckenberger M
Radiother Oncol; 2020 Jan; 142():210-216. PubMed ID: 31431371
[TBL] [Abstract][Full Text] [Related]
17. A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer.
Saitoh JI; Shirai K; Abe T; Kubo N; Ebara T; Ohno T; Minato K; Saito R; Yamada M; Nakano T;
Anticancer Res; 2018 Feb; 38(2):885-891. PubMed ID: 29374716
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models.
Li QW; Qiu B; Wang B; Zhang J; Chen L; Zhou Y; Qin JK; Guo SP; Xie WH; Hui ZG; Liang Y; Guo JY; Wang H; Zhu M; Shen WT; Duan LY; Chen LK; Zhang L; Long H; Wang YM; Liu H
Radiother Oncol; 2019 Jul; 136():98-105. PubMed ID: 31015136
[TBL] [Abstract][Full Text] [Related]
19. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma.
Liu F; Farris MK; Ververs JD; Hughes RT; Munley MT
Radiother Oncol; 2024 Jun; 195():110257. PubMed ID: 38548113
[TBL] [Abstract][Full Text] [Related]
20. Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions.
Karger CP; Peschke P; Scholz M; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):450-5. PubMed ID: 23474116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
